Application of the Pulse Inversion Grayscale Imaging with Levovist Contrast Echo to Increased the Detection Rate of Hepatic Tumor

莫国强,刘学明,潘敏强,陈伟,张闻,许俊

DOI: https://doi.org/10.3760/j.issn:1004-4477.2002.11.006

2002-01-01

Abstract:Objective To assess the evaluation of the pulse inversion imaging with levovist in hepatic tumor. Methods Thirty five cases with hepatic tumor were examined with pluse inversion imaging, levovist was injected intravenously by a microinfusion pump in a 2.5 g dose at a concentration of 357 mg/ml, with a 7 ml normal saline flush, by using 2 ml/min. Flow imaging was shown at low MI( 0.4 ), blood vessels were uniformly bright. Grayscale imaging of the liver parenchyma was performed at high MI( 1.3 ) with an interval duration about 10～20 seconds. Results Of the 14 cases with metastatic tumors,12 cases revealed marked enhanced echo of liver parenchyma adjacent to tumor,8 cases displayed no enhancement in intratumoral echo and hypoechoic appearance, comparing with before contrast enhancment, new lesions were found in 3 cases, the smallest lesions were 3 mm in size.The enhanced echo of liver parenchyma adjacent to the carcinoma showed varieties in 18 cases of hepatocellular carcinoma, and enhancement of the intratumoral echo showed heterogeneous in 16 cases, new lesions were detected in 4 cases.The metastatic tumors were significantly different from primary hepatic tumor in the morphologic characteristic of these tumor vessels with pulse inversion imaging of blood flow. Another 3 cases,the nodular hyperplasia and angioleiomyliporma with carceration, hepatic adenoma revealed significant contrast echo. Conclusions Intravenous injection of ultrasound contrast agent and pulse inversion grayscale imaging could increase the detection of hepatic tumor. Flow imaging has an important value to differentiate the primary liver cancer from metastases lesions.